The spinocerebellar ataxias (SCAs) are a class of hereditary neurodegenerative diseases, which are caused by the pathological expansion of unstable CAG triplet repeats found in a number of apparently unrelated genes. The proteins encoded by the SCA genes typically translate this expanded (CAG) n repeat into an expanded poly(Q) stretch. Several pathological features are common to all SCAs, irrespective of the gene harbouring the expansion. The specific contributions of the mutated genes are currently hard to assess, as the physiological role of most of the so-called ataxins is not known. By combining the results of profile-based sequence analysis with genome-wide functional data available for model organisms, we have derived detailed predictions of the physiological function of two SCA gene products. Ataxin-3, the protein mutated in Machado Joseph Disease (SCA3), belongs to a novel group of cysteine-proteases and is predicted to be active against ubiquitin chains or related substrates. The catalytic site of this enzyme class is similar to that found in UBP and UCH type ubiquitin proteases. For ataxin-7, the gene product of the SCA7 gene, we have identified an orthology relationship to the yeast open reading frame Ygl066c. Recently published evidence from genome-wide studies suggests that Ygl066c is a component of the SAGA histone acetyltransferase complex. By analogy, a similar role for the mammalian ataxin-7 can be expected. The functional predictions reported here are sufficiently precise to allow a direct experimental verification. Moreover, both findings have implications for the general pathogenesis of spinocerebellar ataxias by providing a direct connection of these diseases with ubiquitin metabolism and histone acetylation.
INTRODUCTION
It is a frequently occurring situation that genes causative for a disease state are identified by positional cloning approaches, yet the molecular function of the associated gene productsand thus the pathogenic mechanism-remains obscure. Contemporary bioinformatics approaches frequently allow a reliable prediction of disease gene function, ideally providing a prediction detailed enough for a straightforward experimental validation. In the past, this bioinformatical approach had to rely exclusively on the detection of homology to other proteins that are better characterized and allowed the prediction of some functional analogies. While this component continues to be of crucial importance, there is now a wealth of genomic information available that can be successfully tapped for the purpose of functional prediction. Useful data sources include yeast two-hybrid interaction data, protein complex data, genetic interaction data, structural data and co-expression data. Here, we demonstrate this integration of genomic information using two examples from the field of neurodegeneration.
Ataxin-3 (MJD1) and ataxin-7 are the protein products encoded by two genes mutated in different forms of spinocerebellar ataxia, SCA3 and SCA7 (1, 2) . Both proteins harbour an uninterrupted stretch of multiple glutamine residues, which is considerably longer in the disease state as a consequence of the pathological expansion of an unstable (CAG) n triplet repeat found in the coding portion of the SCA genes. The expanded poly(Q) region in the protein products is thought to contribute crucially to SCA pathogenesis, as these proteins induce the formation of intranuclear inclusion bodies. The mutated proteins are found within these inclusions, typically associated with other components such as ubiquitin and chaperones. Despite a lot of research into this topic, the pathological mechanism of this class of diseases is not entirely clear and several pathogenesis models exist, which are not mutually exclusive. Poly(Q) inclusions are known to sequester other glutamine-rich proteins, which might be required in soluble form for cell viability (3) (4) (5) . In model organisms, poly(Q) toxicology can be rescued by overexpression of chaperones, suggesting an involvement of the cellular quality control mechanism in pathogenicity, an idea supported by the presence of ubiquitin and proteasome components in the inclusion bodies. Finally, a loss-of-function of the mutated protein might contribute substantially to the disease. In most cases, this latter contribution cannot really be assessed as the function of many ataxins is not known.
By combining the generalized sequence profile method with the generation of multiple alignments from structural superposition, we found that ataxin-3 (MJD1), the protein mutated in Machado Joseph Disease, is distantly related to a class of ubiquitin-specific proteases. The known active site residues of this protease class are perfectly conserved in ataxin-3 and its close relatives, suggesting that the MJD1 gene product encodes a catalytically active cysteine protease. Based on the domain context and the published interaction data, we predict that ataxin-3 is active against poly-ubiquitin chains or related substrates. For ataxin-7, which does not bear any resemblance to ataxin-3 except for the expandable poly(Q) stretch, we found a number of conserved homology domains, including a novel Zn-finger motif. The same domain architecture is shared by Ygl066w, a functionally uncharacterized protein from Saccharomyces cerevisiae. Based on the published interaction properties of this yeast protein, Ygl066w has been predicted to be a component of the general transcription machinery, more specifically of the SAGA histone acetyltransferase complex. By analogy, a similar role for the mammalian ataxin-7 is to be expected, which makes this protein an excellent candidate for the proposed link between poly(Q) pathology and histone acetylation.
RESULTS

Ataxin-3
In a previous attempt to derive hints about ataxin-3 function from its polypeptide sequence, we reported the presence of multiple copies of the UIM (ubiquitin interaction motif) in the C-terminal portion of the protein (6) . UIMs are short conserved motifs of about 11 amino acids that occur in many proteins working in pathways of protein ubiquitination and ubiquitinrecognition (6, 7) . In the course of this published work it became obvious that the human genome encodes several ataxin-3-like proteins and that the N-terminal part of ataxin-3 is the most highly conserved portion of the protein. We were thus interested to learn more about the functional role of this protein domain.
In the first step, current versions of the protein database were searched for proteins with similarity to the ataxin-3 N-terminal domain. In order to obtain the full complement of mammalian ataxin-3-like proteins, the Ensembl version of the human genome database (8) and translated versions of the current mammalian EST databases were also searched. As shown in Figure 1 , it was possible to identify four ataxin-3-like proteins in mammals. Besides ataxin-3 there is one closely related protein, which we call ataxin-3-like 1 (Atx3L1), sharing the same domain architecture comprising the conserved N-terminal domain followed by multiple UIMs and a poly(Q) stretch. Two shorter proteins that have been published before as josephin-1 and josephin-2 consist of not much more than the N-terminal domain (9) . Nematodes and plants seem to possess two ataxin-3-like proteins, one of them corresponding to the long form, the other to the short josephin-form, while insects only have a copy of the latter. There is no evidence for ataxin-3-like proteins in yeasts, but there are two proteins of that class found in the parasite Plasmodium falciparum. In the longer plasmodium protein, the conserved ataxin-3 N-terminal domain is followed by a ubiquitin-like UBX domain instead of the UIM motifs (Fig. 1A) . In the hope of finding more distantly related members of this family with some degree of functional annotation, we constructed generalized profiles from the multiple alignment shown in Figure 1B . Unfortunately, no related proteins could be identified in this screen, using the stringent criterion of P < 0.01 (data not shown).
However, we serendipitously obtained useful similarity information on the ataxin-3 N-terminal domain family by using a completely different screen that was originally targeted for identifying new activating proteases for ubiquitin and related modifiers. After exhaustive application of conventional generalized profile searches starting from multiple alignments of the UCH protease family, we tried to make the profile searches more sensitive to very distantly related outlier sequences by incorporating information from three-dimensional structures into the profile construction process. According to the FSSP database (10) , which holds information on structural relationships calculated by the Dali algorithm, the closest known structural neighbour of the UCH-L3 protease (PDB:1UCH) is a leader protease (PDB:1QMY) from the foot and mouth disease virus. The corresponding sequences do not show any recognizable similarity, although the general fold and the active site geometry of the two enzyme classes are clearly related. The spdbv program (11) was used to calculate a rigidbody superposition of the two structures. From this superposition, a structurally valid two-sequence alignment was derived; a number of manual adjustments were required to overcome the rigid-body limitations. Starting from this, generalized profile searches were performed resulting in the incorporation of other UCH proteases and members of the viral protease class into the structure-based alignment.
In this database search, several high-significance matches to members of the UBP family of ubiquitin-specific proteases were obtained. The significant sequence relationship between the UCH and UBP classes of ubiquitin proteases was somewhat surprising. However, the recently published structure of HAUSP (12), the first structurally characterized UBP protease, clearly demonstrates the structural relationship and active site correspondence between these two protease classes. Thus, the significant profile scores obtained in our screen are biologically meaningful and underscore the suitability of our approach. We further refined the structure-based profile searches by also including members of the UBP family into the training set. The resulting profile, consisting of members of the three protease classes, found significant matches to several members of the ataxin-3 family described above. While not all of the structural features of the UCH/leader protease/UBP profile can be reliably mapped to the ataxin-3 sequence, the catalytically most important regions can be aligned with high confidence (Fig. 2) . The catalytic cysteine residue corresponds to C 14 of human ataxin-3, while the proton-donating histidine residue corresponds to the H 119 position. As the third residue of the catalytic triad, an aspartate is observed in all UCH and viral proteases, while in UBP proteases either aspartate or asparagine can be found in that position. Members of the ataxin-3 family share this variability: ataxin-3 itself carries an asparagine (N 134 ) while most other ataxin-3 like proteins use an aspartate instead.
Based on the statistically significant profile comparison scores and the conservation of the catalytically important residues, it is predicted that all members of the ataxin-3 family are cysteine proteases assuming the same fold as UCH, UBP and FMDV leader proteases, i.e. the papain fold (13) . The UBP-type proteases contain a well-conserved asparagine or glutamine residue shortly upstream of the catalytic cysteine, which balances the oxyanion hole of the transition state, probably in a concerted manner with another hydrogen bond providing group from either a backbone imino-or side chain amino-group (12); this feature is also shared by papain and most other proteases belonging to this fold (13) . Ataxin-3 and its relatives carry a highly conserved glutamine residue at the corresponding position, which is likely to assist in the catalytic reaction. The substrate specificity of ataxin-3 cannot be derived from this kind of bioinformatical analysis. However, the presence of a UIM domain in ataxin-3 and the presence of a UBX domain in the plasmodium homolog suggest a role of this protein family in ubiquitin-dependent pathways.
Ataxin-7
Ataxin-7, the protein product of the SCA7 gene, is a protein of 892 amino acids, which carries an expandable poly(Q) region close to the N-terminus. No homologs of ataxin-7 in species other than human have been described and no functional information on that protein is available. Sequence database searches with BLAST (14) identified a number of closely related sequences from vertebrates, including two human paralogues, plus a number of dubious matches of borderline significance, several of which seem to be caused by the extended compositionally biased regions of the ataxin-7 protein sequence. Comparison of ataxin-7 with its ortho-and paralogues from various organisms revealed the existence of three conserved sequence blocks indicated in Figure 3 . In an attempt to find more distantly related, but functionally characterized, homologues of ataxin-7, we used generalized profile searches starting from multiple alignments of the three conserved regions. Two of those regions, spanning ataxin-7 residues from 132-176 and 341-387, respectively, yielded highly significant scores to ORFs from both fission yeast and budding yeast (Fig. 3B) . In particular, the second block was found to be highly conserved and reached significance values P < 10 À6 . The third block conserved in the human ataxin-7 paralogue family was absent in the group of yeast proteins. A closer inspection of the conservation patterns in blocks 1 and 2 revealed a high number of invariant residues with the potential to coordinate metal ions. Block 1 contains five totally conserved positions, two of them occupied by cysteine and one by histidine. The better conserved block '2' has 18 invariant residues, among them three cysteines, two aspartates and one histidine. A conservation pattern like this is typical of metal-binding proteins, including metallo-enzymes.
The identification of a Saccharomyces homolog of ataxin-7 opens new avenues to the elucidation of ataxin-7 function, as a large body of genome-wide functional data is available for yeast (15) . Although Ygl066w, the budding yeast orthologue of ataxin-7, has not been addressed by targeted research so far, it has been covered by two informative systematic studies: first, the published Cellzome screen for multi-protein complexes in yeast (16) has identified Ygl066w as a component of two complexes with widely overlapping subunit composition. Complex 420 using Spt7 as a bait, and complex 442 using Taf90 as bait, were found to contain Ygl066w together with a number of other proteins shown in Table 1 . Most proteins found in the same complexes as Ygl066w are well-known components of both the TBP-associated complex and of the SAGA histone acetyltransferase complex. Even more informative was a recently published study by Sanders et al. (17) using a similar approach but focussing on TBP-associated proteins. According to their data, Ygl066w interacts exclusively with the TAF proteins of the SAGA complex (which are also found in the TBP complex), but not with those occurring in the TBP complex alone. The obvious explanation, that Ygl066w is a new component of the yeast SAGA complex, was corroborated by additional interaction studies (17) . The SAGA complex is a multi-subunit assembly conserved from yeast to human, which regulates transcription by histone acetylation. Although no functional information on ataxin-7 and its paralogues is available, there is a high probability that all of these proteins are components of SAGA-like histone acetyltransferase complexes, maybe in a tissue-specific manner.
DISCUSSION
Ataxin-3
Ataxin-3 is the protein mutated in Machado Joseph Disease (MJD, SCA3), the most common form of hereditary spinocerebellar ataxias. Based on the results of our sequence analysis, we predict ataxin-3 to be a cysteine protease assuming the papain fold, that is structurally and functionally related to two quite divergent subfamilies of ubiquitin-specific proteases, the UCH and the UBP enzymes. Several other pieces of evidence provide additional links between ataxin-3 and the protein ubiquitination pathway: (i) the inclusion bodies of SCA3 contain tightly bound ubiquitin and components of the proteasome (18); (ii) wild-type ataxin-3 contains two or three copies of the ubiquitin-binding UIM motif (6) and has been found to physically interact with Rad23, a ubiquitin-domain containing protein; (iii) the plasmodium homolog of ataxin-3 contains a C-terminal UBX domain. UBX domains were originally identified as conserved regions of unknown function that frequently associated with ubiquitin-binding UBA domains (19) . Nowadays, UBX domains are known to be structurally related to ubiquitin; they also exhibit a similar interaction pattern (20) .
The conservation pattern of the ataxin-3 family does not allow the prediction of the enzymatic substrates. Even the sequence relationship to the ubiquitin-specific UCH and UBP families does not provide a direct link to substrate preference, as this group also includes the viral leader peptidases that are not active against ubiquitin. Nevertheless, the published biochemical properties of ataxin-3, combined with the domain architecture of ataxin-3 and its close relatives suggest an involvement in the ubiquitin pathway. An obvious hypothesis for ataxin-3 function would thus predict a proteolytic activity against components of the ubiquitin pathway, possibly against ubiquitin itself. Several ubiquitin proteases contain ubiquitinbinding domains in addition to the catalytic portion of the enzyme. The role of these ancillary domains has not been firmly established so far. We favour the hypothesis that the noncatalytic domains of UBPs have a role in substrate recognition. The presence of a non-catalytic ubiquitin-binding domain would, according to this hypothesis, suggest a specificity for polyubiquitin chains, potentially with preference of one chain topology over the others. Some support for this idea can be derived from the chain-preferring properties of isopeptidase T, a UBP-type ubiquitin protease with a ubiquitin-binding UBA domain in its non-catalytic portion (21) .
If the prediction holds true, ataxin-3 would join the ranks of several other deubiquitinases associated with neurodegenerative diseases: (i) the ubiquitin C-terminal hydrolase UCH-L1 is mutated in PARK5, a juvenile form of Parkinson disease (22) ; (ii) in the mouse, mutations of UCH-L1 are the cause of a naturally occurring neurodegenerative condition called 'gad' ataxia (23) ; the 'gad' disease phenotype can be acerbated by UCH-L3 deletion, suggesting that the disease is due to a proteolytic defect (24) ; (iii) another spontaneously occurring ataxia model of the mouse, the ax(J) ataxia, is caused by defects in the UBP-type protease USP14 (25) ; and (iv) the UBP type protease USP7/HAUSP has been found to bind to wildtype, but not to poly(Q) expanded ataxin-1 (26) . Currently, it is not clear if the cause of the disease is a pathological ubiquitin depletion due to insufficient turnover, or if the deubiquitination has a signalling role.
Recently, ataxin-3 has been proposed to be related to an allalpha helical domain found in the N-terminus of adaptins, epsins, and other proteins involved in endocytosis (9). This proposed relationship was mainly based on a similar content and arrangement of secondary structure elements and was refined by a threading analysis using the adaptin180 structure as a template. We agree with the authors of this study that the N-terminal domain of ataxin-3 (also called 'josephin-domain') consists mainly of alpha helices. However, the prediction of an evolutionary relationship between adaptins and the ataxin-3 N-terminus is in contradiction with our findings. A comparison of the three-dimensional structures of various protease families adopting the papain fold shows a large degree of variability outside of the catalytically important region (13) . The catalytic cysteine residue is invariably part of an alpha-helical structure, while the catalytic histidine and the orienting glutamate/ glutamine residue are found in a beta-strand context (compare Fig. 2A ). While these beta-strands can be fairly short, they are invariably present in this protease class, thus making our prediction also structurally incompatible with the all-alpha fold of the adaptin/epsin domain.
We consider the significant profile matches, in combination with the observed invariance of the catalytic residues, a more convincing indicator of protein relationships than a threading analysis. Additionally, there is little experimental support for a role of ataxin-3 in endocytosis. The presence of UIM motifs has been used to that end (9), although UIMs are not really a hallmark of endocytosis proteins but rather indicators of ubiquitin binding (6, 27, 28) . Ataxin-3 has been reported to localize to the nucleus and to have an effect on transcriptional activation. Both findings are much easier to reconcile with a function of ataxin-3 as a ubiquitin protease rather than as an endocytosis protein.
Ataxin-7
By using profile-based sequence analysis, we found that the yeast protein Ygl066w is a likely fungal orthologue of a human paralogy group containing ataxin-7 and two more uncharacterized proteins. As Ygl066w is a bona fide subunit of the SAGA histone acetyltransferase complex, the observed relationship strongly suggests that ataxin-7 is involved in histone acetylation, too. The exact role of the ataxin-7 like proteins in this complex is not clear, although the observed pattern of residue invariance suggests a role involving two or more metal ions, potentially in an enzymatic context. If ataxin-7 has an enzymatic activity, its exact nature cannot be predicted from our data.
Nevertheless, this newly found direct connection between a SCA-mutated gene and histone acetylation is intriguing. On several occasions, neurodegenerative diseases arising by triplet instability have been found connected to histone modifications. In a genetic screen for modifiers of ataxin-1 toxicity, the acetylation regulators Sin3a, Rpd3, CtBP and Sir2 have been identified (29) . Furthermore, inhibitors of histone deacetylation have been found to reduce poly(Q) mediated toxicity in a Drosophila model system (30) . Both results are compatible with a model where histone acetylase components required for cell viability are sequestered to poly(Q) inclusion bodies. So far, transcriptional cofactors like CtBP have been considered prime candidates (31), as they have been found to bind to glutamine-expanded fragments of huntingtin or ataxin-1. Based on our analysis, a role of ataxin-7 in poly(Q)-mediated histone acetylase depletion is an attractive alternative hypothesis-at least in the case of SCA7, where ataxin-7 is known to be sequestered in inclusion bodies. As poly(Q) inclusions are known to sequester other poly(Q) proteins as well, even in their wild-type form, a role of ataxin-7 in other poly(Q) diseases is also conceivable.
General implications for poly(Q) pathogenesis
One of the major questions in understanding the pathology of poly(Q) expansion diseases is the specific role of the mutated protein. Would any protein with a poly(Q) stretch exceeding a certain threshold and having a sufficiently high neuronal expression level be able to cause a neurodegenerative disease? This idea is supported by a number of observations, discussed in recent review literature (32, 33) . Some phenotypic aspects of poly(Q) diseases caused by mutations in different genes are strikingly similar, including the formation of intranuclear inclusion bodies. It has been demonstrated that these inclusions sequester several cellular proteins, including ubiquitin, proteasome components, chaperones, transcriptional activators and poly(Q) containing proteins in general. Much less clear, however, is the question if this sequestration is part of the pathogenesis mechanism (by depleting the cells of these essential factors) or rather a part of a rescue mechanism (by storing harmful mutant proteins in an inaccessible form). The recruitment of chaperones and components of the protein degradation mechanism can be interpreted as an attempt of the cell to get rid of the mutant proteins.
A number of recent studies have highlighted the importance of the mutated protein and its interaction partners for the disease mechanism (26, 34, 35) . During the last years, several interaction partners of ataxins and other poly(Q) expanded proteins have been identified, and quite frequently the interaction propensity was sharply modulated by the length of the polyQ stretch. Both among genes causing neurodegeneration and among their interaction partners, proteins of the ubiquitin pathway are clearly over-represented: genes mutated in Parkinson disease include the ubiquitin ligase parkin and the ubiquitin protease UCH-L1; ataxin-1 interacts with the ubiquitin protease HAUSP (26); the huntingtin interacting protein HIP2 is a ubiquitin conjugating enzyme with an additional UBA domain (36) ; the androgen receptor (polyQexpanded in SBMA) interacts with SARIP (TrEMBLAcc.:Q99ND9), a UEV domain protein, and with ARA54, a RING-finger ubiquitin ligase with an additional UEV domain (37) , to name just a few examples. Ataxin-3, which interacts with ubiquitin and with the UBA protein Rad23 (38), seems to follow this trend. Notably, most of the interactions mentioned here occur with wild-type proteins, suggesting that ubiquitin recruitment to the inclusion bodies might not only be due to the poly(Q) expansion, but rather are caused by intrinsic properties of the affected genes.
One of the most intriguing results from the study of invertebrate models of poly(Q) diseases was the modification of the disease severity by regulators of histone acetylation and the rescue by inhibitors of histone deacetylation (30, 39) . These observations point strongly towards a role of the general transcription regulation machinery in poly(Q) pathology. Many transcriptional regulators contain oligo(Q) stretches and their recruitment to poly(Q) inclusions by virtue of this feature is conceivable. The depletion of ataxin-7, which we predict to be a component of the SAGA complex, could be another factor contributing to an overall decrease of histone acetylation. It will be interesting to test if overexpression of wild-type ataxin-7 is able to rescue the ataxia phenotype in poly(Q) diseases other than SCA7. Finally, it should be noted that the same studies identifying the yeast orthologue of ataxin-7 as a SAGA subunit also found the ubiquitin protease Ubp8 as an additional subunit of this complex (16, 17) . This unexpected link between histone acetylation and the ubiquitin pathway might offer a first glimpse of a unified theory of spinocerebellar ataxia pathogenesis.
MATERIALS AND METHODS
All sequence database searches were performed with a nonredundant data set constructed from current releases of SwissProt, TrEMBL, and GenPept (40, 41) . Generalized profile construction (42) and searches were run locally using the pftools package, version 2.1. (program available from the URL ftp:// ftp.isrec.isb-sib.ch/sib-isrec/pftools/). Generalized profiles were constructed using the BLOSUM45 substitution matrix (43) and default penalties of 2.1 for gap opening and 0.2 for gap extension. The statistical significance of profile matches was derived from the analysis of the score distribution of a randomized database (44, 45) . Database randomization was performed by individually inverting each protein sequence, using SwissProt 34 as the data source. Only sequence matches found with a probability of P < 0.01 were included into subsequent rounds of iterative profile refinement. As discussed in Hofmann (45) , the probability values obtained by randomization scaling of profiles are much more reliable than those obtained from theoretical scaling methods using assumptions of uniformity of sequence composition. Sequences were assembled from expressed sequence tag and genomic data provided by the NCBI and the Ensembl project (8) . Structural superposition and generation of structurally correct multiple alignments were performed using the spdbv program (11) . Information on structural neighbours was obtained from the FSSP database (10) . Dendrogram analysis was performed using the 'neighbour joining' algorithm (46) . Secondary structure prediction were performed by the Psipred server (47) and by the PredictProtein network service running the PROF method (48) .
